Approach to the patient with eosinophilia in the era of tyrosine kinase inhibitors and biologicals
In this review, we aim to explore the optimal approach to patients presenting with eosinophilia, considering recent advances in diagnostic and therapeutic strategies. Specifically, we focus on the integration of novel therapies into clinical practice to improve patient outcomes.
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
October 2024
|
| In: |
Current hematologic malignancy reports
Year: 2024, Volume: 19, Issue: 5, Pages: 208-222 |
| ISSN: | 1558-822X |
| DOI: | 10.1007/s11899-024-00738-7 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s11899-024-00738-7 Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s11899-024-00738-7 
|
| Author Notes: | Johannes Lübke, Georgia Metzgeroth, Andreas Reiter, Juliana Schwaab |
| Summary: | In this review, we aim to explore the optimal approach to patients presenting with eosinophilia, considering recent advances in diagnostic and therapeutic strategies. Specifically, we focus on the integration of novel therapies into clinical practice to improve patient outcomes. |
|---|---|
| Item Description: | Online veröffentlicht: 22. Juli 2024 Gesehen am 20.11.2024 |
| Physical Description: | Online Resource |
| ISSN: | 1558-822X |
| DOI: | 10.1007/s11899-024-00738-7 |